Dolby Laboratories Quarterly Balance Sheet
NYSE: DLBMiscellaneousMulti-Sector CompaniesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Dolby Laboratories financial position
As of Jun 26, 2026, Dolby Laboratories reported total assets of $3.16 billion, down 1.2% from a year earlier against total liabilities of $563.9 million. Shareholders' equity stood at $2.58 billion, or 81.8% of assets. The company held $669.4 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 3.19, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Dolby Laboratories balance sheet (quarterly)
| Quarter (USD) | Q3 20262026-06-26 | Q2 20262026-03-27 | Q1 20262025-12-26 | Q4 20252025-09-26 | Q3 20252025-06-27 | Q2 20252025-03-28 | Q1 20252024-12-27 | Q4 20242024-09-27 | Q3 20242024-06-28 | Q2 20242024-03-29 | Q1 20242023-12-29 | Q4 20232023-09-29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 669.39M | 594.28M | 643.85M | 701.89M | 698.57M | 626.55M | 520.82M | 482.05M | 741.64M | 709.53M | 656.82M | 745.36M |
| Short-Term Investments | 652.00K | 460.00K | 739.00K | 703.00K | 763.00K | — | — | 0 | 127.32M | 115.86M | 140.82M | 139.15M |
| Receivables | 285.15M | 391.29M | 373.09M | 331.10M | 297.61M | 314.11M | 339.30M | 315.46M | 285.84M | 282.13M | 293.23M | 262.25M |
| Inventory | 30.77M | 31.93M | 31.26M | 30.42M | 32.41M | 34.59M | 31.83M | 33.73M | 34.72M | 35.80M | 37.57M | 35.62M |
| Total Current Assets | 1.33B | 1.41B | 1.41B | 1.39B | 1.34B | 1.39B | 1.29B | 1.19B | 1.47B | 1.55B | 1.45B | 1.49B |
| Property, Plant & Equipment | 459.12M | 461.84M | 466.72M | 470.61M | 478.48M | 472.66M | 476.11M | 479.11M | 477.69M | 481.49M | 479.32M | 481.58M |
| Goodwill | 528.34M | 529.67M | 530.30M | 529.90M | 528.82M | 525.02M | 520.42M | 533.21M | 408.46M | 408.65M | 410.44M | 408.41M |
| Intangible Assets | 382.43M | 389.71M | 364.02M | 397.06M | 408.15M | 412.06M | 421.24M | 434.51M | 144.64M | 152.15M | 159.89M | 167.43M |
| Long-Term Investments | 86.44M | 81.22M | 85.02M | 80.20M | 78.02M | 73.76M | 86.30M | 89.27M | 117.90M | 127.97M | 92.88M | 97.81M |
| Total Assets | 3.16B | 3.25B | 3.19B | 3.23B | 3.20B | 3.23B | 3.16B | 3.11B | 2.97B | 3.04B | 2.94B | 2.98B |
| Accounts Payable | 12.47M | 20.69M | 8.67M | 17.84M | 17.23M | 17.29M | 11.55M | 17.38M | 16.41M | 19.73M | 14.39M | 20.93M |
| Total Current Liabilities | 416.33M | 474.61M | 443.51M | 437.79M | 388.79M | 457.49M | 441.88M | 417.84M | 354.54M | 442.90M | 394.10M | 422.23M |
| Total Liabilities | 563.89M | 622.36M | 589.25M | 595.81M | 581.75M | 646.02M | 641.57M | 623.03M | 526.20M | 607.04M | 573.22M | 607.58M |
| Shareholders' Equity | 2.58B | 2.62B | 2.59B | 2.62B | 2.60B | 2.57B | 2.51B | 2.48B | 2.43B | 2.42B | 2.35B | 2.36B |
| Retained Earnings | 2.60B | 2.63B | 2.60B | 2.63B | 2.62B | 2.60B | 2.54B | 2.50B | 2.46B | 2.45B | 2.37B | 2.39B |
| Net Cash (Debt) | 670.05M | 594.74M | 644.58M | 702.60M | 699.33M | 626.55M | 520.82M | 482.05M | 868.96M | 825.40M | 797.64M | 884.51M |
This table shows 12 quarterly periods of Dolby Laboratories's balance sheet, from Q3 2026 back to Q4 2023, across 16 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow DLB's reporting calendar. What is a balance sheet?